Developing a Neuroimaging Biomarker for Amyotrophic Lateral Sclerosis: Multi-Center Data Sharing and the Road to a “Global Cohort”
Neuroimaging in Amyotrophic Lateral Sclerosis (ALS) has steadily evolved from an academic exercise to a powerful clinical tool for detecting and following pathological change. Nevertheless, significant challenges need to be addressed for the translation of neuroimaging as a robust outcome-metric and...
Main Authors: | Robert Steinbach, Nayana Gaur, Beatrice Stubendorff, Otto W. Witte, Julian Grosskreutz |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2018-12-01
|
Series: | Frontiers in Neurology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fneur.2018.01055/full |
Similar Items
-
Cerebrospinal Fluid Neurofilament Light Chain (NfL) Predicts Disease Aggressiveness in Amyotrophic Lateral Sclerosis: An Application of the D50 Disease Progression Model
by: Marie Dreger, et al.
Published: (2021-04-01) -
Blood–Brain Barrier Disruption Is Not Associated With Disease Aggressiveness in Amyotrophic Lateral Sclerosis
by: Tino Prell, et al.
Published: (2021-10-01) -
Triage of Amyotrophic Lateral Sclerosis Patients during the COVID-19 Pandemic: An Application of the D50 Model
by: Robert Steinbach, et al.
Published: (2020-09-01) -
Diagnostic Circulating miRNAs in Sporadic Amyotrophic Lateral Sclerosis
by: A. Panio, et al.
Published: (2022-05-01) -
Structural and functional neuroimaging in amyotrophic lateral sclerosis
by: Ilya S. Bakulin, et al.
Published: (2017-08-01)